Terms: = Uterine cancer AND ABL1, p150, 25, ENSG00000097007, P00519, v-abl, bcr/abl, JTK7, c-ABL, ABL, BCR-ABL AND Clinical Outcome
128 results:
1. Post-surgical ctDNA-based molecular residual disease detection in patients with stage I uterine malignancies.
Recio F; Scalise CB; Loar P; Lumish M; Berman T; Peddada A; Kalashnikova E; Rivero-Hinojosa S; Beisch T; Nicosia B; Farmer T; Dutta P; Malhotra M; ElNaggar AC; Liu MC; Vaccarello L; Holloway RW
Gynecol Oncol; 2024 Mar; 182():63-69. PubMed ID: 38262240
[TBL] [Abstract] [Full Text] [Related]
2. Performance of the WID-qEC test versus sonography to detect uterine cancers in women with abnormal uterine bleeding (EPI-SURE): a prospective, consecutive observational cohort study in the UK.
Evans I; Reisel D; Jones A; Bajrami A; Nijjar S; Solangon SA; Arora R; Redl E; Schreiberhuber L; Ishaq-Parveen I; Rothärmel J; Herzog C; Jurkovic D; Widschwendter M
Lancet Oncol; 2023 Dec; 24(12):1375-1386. PubMed ID: 37944542
[TBL] [Abstract] [Full Text] [Related]
3. clinical outcome and biomarker assessments of a multi-centre phase II trial assessing niraparib with or without dostarlimab in recurrent endometrial carcinoma.
Madariaga A; Garg S; Tchrakian N; Dhani NC; Jimenez W; Welch S; MacKay H; Ethier JL; Gilbert L; Li X; Rodriguez A; Chan L; Bowering V; Clarke B; Zhang T; King I; Downs G; Stockley T; Wang L; Udagani S; Oza AM; Lheureux S
Nat Commun; 2023 Mar; 14(1):1452. PubMed ID: 36922497
[TBL] [Abstract] [Full Text] [Related]
4. Early outcomes of abbreviated multi-fractionated brachytherapy schedule for cervix cancer during COVID-19 pandemic.
Chopra S; Mulani J; Mittal P; Singh M; Shinde A; Gurram L; Scaria L; Aravindakshan D; Kohle S; Rane P; Ghadi Y; Rath S; Ghosh J; Gulia S; Gupta S; Kinhikar R; Laskar S; Agarwal JP
Brachytherapy; 2023; 22(2):125-131. PubMed ID: 36585283
[TBL] [Abstract] [Full Text] [Related]
5. Endometrial polyps.
Berceanu C; Cernea N; Căpitănescu RG; Comănescu AC; Paitici Ş; Rotar IC; Bohîlţea RE; Olinca MV
Rom J Morphol Embryol; 2022; 63(2):323-334. PubMed ID: 36374138
[TBL] [Abstract] [Full Text] [Related]
6. Image-guided adaptive brachytherapy for advanced cervical cancer spreading to the bladder and/or rectum: clinical outcome and prognostic factors.
Ka K; Laville A; Rassy E; Ayachi RE; Pautier P; Ba MB; Bockel S; Achkar S; Espenel S; Maulard A; Morice P; Gouy S; Haie-Meder C; Sun R; Chargari C
Gynecol Oncol; 2023 Jan; 168():32-38. PubMed ID: 36370612
[TBL] [Abstract] [Full Text] [Related]
7. clinical outcome of FIGO 2018 stage IB3/IIA2 cervical cancer treated by neoadjuvant chemotherapy followed by radical surgery due to lack of radiotherapy equipment: A retrospective comparison with concurrent chemoradiotherapy.
Zeng J; Sun P; Ping Q; Jiang S; Hu Y
PLoS One; 2022; 17(3):e0266001. PubMed ID: 35324998
[TBL] [Abstract] [Full Text] [Related]
8. Magnetic Resonance Imaging-Guided Adaptive Brachytherapy for the Treatment of Cervical cancer and its Impact on clinical outcome.
Singhal S; Veeratterapillay J; Locks S; Morgan D; Patil R; Chamberlain HM
Clin Oncol (R Coll Radiol); 2022 Jul; 34(7):442-451. PubMed ID: 35123850
[TBL] [Abstract] [Full Text] [Related]
9. The Impact of Histological Subtype on Survival outcome of Patients with Stage IIB-IVA Cervical cancer Who Received Definitive Radiotherapy.
Miyahara S; Tsuji K; Shimada M; Shibuya Y; Shigeta S; Nagai T; Umezawa R; Tokunaga H; Jingu K; Yaegashi N
Tohoku J Exp Med; 2021 Dec; 255(4):303-313. PubMed ID: 34911878
[TBL] [Abstract] [Full Text] [Related]
10. Quality of life and long-term clinical outcome following robot-assisted radical trachelectomy.
Ekdahl L; Crusensvärd M; Reynisson P; Lönnerfors C; Persson J
Eur J Obstet Gynecol Reprod Biol; 2021 Dec; 267():234-240. PubMed ID: 34837852
[TBL] [Abstract] [Full Text] [Related]
11. Minimal uterine serous carcinoma and endometrial polyp: a close clinicopathological relationship.
Assem H; Rottmann D; Finkelstein A; Wang M; Ratner E; Santin AD; Buza N; Hui P
Hum Pathol; 2021 Dec; 118():1-8. PubMed ID: 34508766
[TBL] [Abstract] [Full Text] [Related]
12. Combination of Radiomics and Machine Learning with Diffusion-Weighted MR Imaging for clinical outcome Prognostication in Cervical cancer.
Jajodia A; Gupta A; Prosch H; Mayerhoefer M; Mitra S; Pasricha S; Mehta A; Puri S; Chaturvedi A
Tomography; 2021 Aug; 7(3):344-357. PubMed ID: 34449713
[TBL] [Abstract] [Full Text] [Related]
13. MEK inhibition overcomes resistance to EphA2-targeted therapy in uterine cancer.
Wu Y; Huang J; Ivan C; Sun Y; Ma S; Mangala LS; Fellman BM; Urbauer DL; Jennings NB; Ram P; Coleman RL; Hu W; Sood AK
Gynecol Oncol; 2021 Oct; 163(1):181-190. PubMed ID: 34391578
[TBL] [Abstract] [Full Text] [Related]
14. Long-term clinical outcome and dosimetric comparison of tandem and ring versus tandem and ovoids intracavitary application in cervical cancer.
Atasever Akkas E; Altundag MB
J BUON; 2021; 26(3):698-706. PubMed ID: 34268923
[TBL] [Abstract] [Full Text] [Related]
15. Intraoperative electron beam radiotherapy and perioperative high-dose-rate brachytherapy in previously irradiated oligorecurrent gynecological cancer: clinical outcome analysis.
Jablonska PA; Cambeiro M; Gimeno M; Aramendía JM; Mínguez JA; Alcázar JL; Aristu JJ; Calvo FA; Martínez-Monge R
Clin Transl Oncol; 2021 Sep; 23(9):1934-1941. PubMed ID: 33835408
[TBL] [Abstract] [Full Text] [Related]
16. Treatment outcome of the Combination Therapy of High-dose rate Intracavitary Brachytherapy and Intensity-modulated Radiation Therapy With Central-shielding for Cervical cancer.
Mukai Y; Minagawa Y; Inoue H; Sato A; Matsui K; Fukuda T; Onuma K; Hongo H; Shirata R; Nagata H; Hashimoto H; Inoue T; Hata M; Omura M
In Vivo; 2020; 34(6):3387-3398. PubMed ID: 33144446
[TBL] [Abstract] [Full Text] [Related]
17. Hereditary leiomyomatosis and renal cell carcinoma syndrome associated uterine smooth muscle tumors: Bridging morphology and clinical screening.
Garg K; Rabban J
Genes Chromosomes Cancer; 2021 Mar; 60(3):210-216. PubMed ID: 33099845
[TBL] [Abstract] [Full Text] [Related]
18. Mutation profiling of uterine cervical cancer patients treated with definitive radiotherapy.
Yoshimoto Y; Sasaki Y; Murata K; Noda SE; Miyasaka Y; Hamamoto J; Furuya M; Hirato J; Suzuki Y; Ohno T; Tokino T; Oike T; Nakano T
Gynecol Oncol; 2020 Nov; 159(2):546-553. PubMed ID: 32951893
[TBL] [Abstract] [Full Text] [Related]
19. HER2 Testing in Endometrial Serous Carcinoma: Time for Standardized Pathology Practice to Meet the clinical Demand.
Buza N
Arch Pathol Lab Med; 2021 Jun; 145(6):687-691. PubMed ID: 32649220
[TBL] [Abstract] [Full Text] [Related]
20. TNFα signalling predicts poor prognosis of patients with endometrial cancer.
Wieser V; Abdel Azim S; Sprung S; Knoll K; Kögl J; Hackl H; Marth C; Zeimet AG; Fiegl H
Carcinogenesis; 2020 Aug; 41(8):1065-1073. PubMed ID: 32301486
[TBL] [Abstract] [Full Text] [Related]
[Next]
